EUVIMEDEUVIMED entdecken
Crossref

Glutamine, a Potential Metabolomic Biomarker and Therapeutic Target in Radiation-induced Liver Damage

Liming Gu, Yang Jiao, Wei Mo, Wenli Wang, Xiedong Hong, Shihong Li, Jianping Cao, Chang Wang

Radiation Research · 04.09.2026 · 206 (5) · 496-510

DOI: 10.1667/rade-25-00236.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Research, erschienen am 04.09.2026. Verfasst von Liming Gu und 7 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiation-induced liver damage (RILD) significantly limits the clinical application of radiotherapy for upper abdominal malignancies. Radiation can induce metabolic disorder in liver tissues. However, there is no systematic research on the effects of radiation on liver metabolism. In this study, we collected time-series liver tissue samples from irradiated rats at multiple time points, from 3 days to 4 weeks after exposure, to reveal dynamic alterations in metabolic profiles throughout RILD progression. Acetylcholic acid, p-hydroxyphenyllactic acid, ascorbic acid, daidzein, and glutamine (Gln) were identified as potential biomarkers, demonstrating good diagnostic sensitivity and specificity. As a metabolomic biomarker, Gln emerged as a potential metabolic target based on pathway enrichment analysis, which could modulate the radiosensitivity of both mouse (JS-1) and human (LX-2) hepatic stellate cells. Transcriptomics, co-immunoprecipitation (Co-IP) and functional rescue experiments demonstrated that the regulation of radiosensitivity by Gln is mediated through the Col1α2/ ITGB1/AKT signaling axis. In the mouse RILD model, Gln prevented irradiation-induced body weight loss, preserved liver structure, and reduced TGF-β and TNF-α expression as well as collagen deposition. L-alanyl-glutamine (Ala-Gln) and liposomes were introduced to further enhance the radioprotective effects of Gln. This study provides the necessary theoretical and experimental basis for diagnosis and intervention of RILD.

Zitieren

APA

Gu, L., Jiao, Y., Mo, W., Wang, W., Hong, X., Li, S., Cao, J., & Wang, C. (2026). Glutamine, a Potential Metabolomic Biomarker and Therapeutic Target in Radiation-induced Liver Damage. Radiation Research, 206(5), 496-510. https://doi.org/10.1667/rade-25-00236.1

Vancouver

Gu L, Jiao Y, Mo W, Wang W, Hong X, Li S, et al. Glutamine, a Potential Metabolomic Biomarker and Therapeutic Target in Radiation-induced Liver Damage. Radiation Research. 2026;206(5):496-510. doi:10.1667/rade-25-00236.1

BibTeX
@article{Gu2026,
  author = {Gu, Liming and Jiao, Yang and Mo, Wei and Wang, Wenli and Hong, Xiedong and Li, Shihong and Cao, Jianping and Wang, Chang},
  title = {Glutamine, a Potential Metabolomic Biomarker and Therapeutic Target in Radiation-induced Liver Damage},
  journal = {Radiation Research},
  year = {2026},
  volume = {206},
  number = {5},
  pages = {496--510},
  doi = {10.1667/rade-25-00236.1}
}
Kostenlos starten →